Clinical & Payment Policies
Clinical Policies
Clinical policies are one set of guidelines used to assist in administering health plan benefits, either by prior authorization or payment rules. They include but are not limited to policies relating to evolving medical technologies and procedures, as well as pharmacy policies. Clinical policies help identify whether services are medically necessary based on information found in generally accepted standards of medical practice; peer-reviewed medical literature; government agency/program approval status; evidence-based guidelines and positions of leading national health professional organizations; views of physicians practicing in relevant clinical areas affected by the policy; and other available clinical information.
All policies found in the Meridian Clinical Policy Manual apply to Meridian members. Policies in the Meridian Clinical Policy Manual may have either a Meridian or a “Centene” heading. Meridian utilizes InterQual® criteria for those medical technologies, procedures or pharmaceutical treatments for which a Meridian clinical policy does not exist. InterQual is a nationally recognized evidence-based decision support tool. You may access the InterQual® SmartSheet(s)™ for Adult and Pediatric procedures, durable medical equipment and imaging procedures by logging into the secure provider portal or by calling Meridian. In addition, Meridian may from time to time delegate utilization management of specific services; in such circumstances, the delegated vendor’s guidelines may also be used to support medical necessity and other coverage determinations. Other non-clinical policies (e.g., payment policies) or contract terms may further determine whether a technology, procedure or treatment that is not addressed in the Clinical Policy Manuals or InterQual®criteria is payable by Meridian.
If you have any questions regarding these policies, please contact Member Services and ask to be directed to the Medical Management department.
- Adopted Clinical Practice and Preventive Health Guidelines (CPG Grid) (PDF)
- Air Ambulance (CP.MP.175) (PDF)
- Allogeneic Hematopoietic Cell Transplants for Sickle Cell Anemia and Beta-thalassemia (CP.MP.108) (PDF)
- Bariatric Surgery (MI.CP.MP.37) (PDF)
- Bronchial Thermoplasty (CP.MP.110) (PDF)
- Burn Surgery (CP.MP.186) (PDF)
- Chiropractic Care (MI.CP.MP.535) (PDF)
- Concert Genetics Oncology: Algorithmic Testing (V2.2024) (PDF)
- Concert Genetics Oncology: Cancer Screening (V2.2024) (PDF)
- Concert Genetics Oncology: Circulating Tumor DNA and Circulating Tumor Cells (Liquid Biopsy) (V2.2024) (PDF)
- Concert Genetics Oncology: Cytogenetic Testing (V2.2024) (PDF)
- Concert Genetics Oncology: Molecular Analysis of Solid Tumors and Hematologic Malignancies (V2.2024) (PDF)
- Concert Genetic Testing: Aortopathies and Connective Tissue Disorders (V2.2024) (PDF)
- Concert Genetic Testing: Cardiac Disorders (V2.2024) (PDF)
- Concert Genetic Testing: Dermatologic Conditions (V2.2024) (PDF)
- Concert Genetic Testing: Epilepsy, Neurodegenerative, and Neuromuscular Conditions (V2.2024) (PDF)
- Concert Genetic Testing: Exome and Genome Sequencing for the Diagnosis of Genetic Disorders (V2.2024) (PDF)
- Concert Genetic Testing: Eye Disorders (V2.2024) (PDF)
- Concert Genetic Testing: Gastroenterologic Disorders (non-cancerous) (V2.2024) (PDF)
- Concert Genetic Testing: General Approach to Genetic and Molecular Testing (V2.2024) (PDF)
- Concert Genetic Testing: Hearing Loss (V2.2024) (PDF)
- Concert Genetic Testing: Hematologic Conditions (non-cancerous) (V2.2024) (PDF)
- Concert Genetic Testing: Hereditary Cancer Susceptibility (V2.2024) (PDF)
- Concert Genetic Testing: Immune, Autoimmune, and Rheumatoid Disorders (V2.2024) (PDF)
- Concert Genetic Testing: Kidney Disorders (V2.2024) (PDF)
- Concert Genetic Testing: Lung Disorders (V2.2024) (PDF)
- Concert Genetic Testing: Metabolic, Endocrine, and Mitochondrial Disorders (V2.2024) (PDF)
- Concert Genetic Testing: Multisystem Inherited Disorders, Intellectual Disability, and Developmental Delay (V2.2024) (PDF)
- Concert Genetic Testing: Non-Invasive Prenatal Screening (NIPS) (V1.2024) (PDF)
- Concert Genetic Testing: Pharmacogenetics (V2.2024) (PDF)
- Concert Genetic Testing: Preimplantation Genetic Testing (V2.2024) (PDF)
- Concert Genetic Testing: Prenatal and Preconception Carrier Screening (V2.2024) (PDF)
- Concert Genetic Testing: Prenatal Diagnosis (via Amniocentesis, CVS, or PUBS) and Pregnancy Loss (V2.2024) (PDF)
- Concert Genetic Testing: Skeletal Dysplasia and Rare Bone Disorders (V2.2024) (PDF)
- Cosmetic and Reconstructive Procedures (CP.MP.31) (PDF)
- Drugs of Abuse: Definitive Testing (CP.MP.50) (PDF)
- Experimental Technologies (CP.MP.36) (PDF)
- Facility Based Sleep Studies for Obstructive Sleep Apnea (CP.MP.248) (PDF)
- Fecal Incontinence Treatments (CP.MP.137) (PDF)
- Gastric Electrical Stimulation (CP.MP.40) (PDF)
- Gender-Affirming Procedures (CP.MP.95) (PDF)
- Heart-Lung Transplant (CP.MP.132) (PDF)
- Home INR Monitor (MI.CP.MP.502) (PDF)
- Hospice Services (CP.MP.54) (PDF)
- Intensity-Modulated Radiotherapy (CP.MP.69) (PDF)
- Intestinal and Multivisceral Transplant (CP.MP.58) (PDF)
- IV Moderate Sedation, IV Deep Sedation, and General Anesthesia for Dental Procedures (CP.MP.61) (PDF)
- Laser Therapy for Skin Conditions (CP.MP.123) (PDF)
- Liposuction for Lipedema (CP.MP.244) (PDF)
- Long Term Care Placement (CP.MP.71) (PDF)
- Lung Transplantation (CP.MP.57) (PDF)
- Multiple Sleep Latency Testing (CP.MP.24) (PDF)
- Neonatal Abstinence Syndrome Guidelines (CP.MP.86) (PDF)
- Neonatal Sepsis Management (CP.MP.85) (PDF)
- Neuromuscular and Peroneal Nerve Electrical Stimulation (NMES) (CP.MP.48) (PDF)
- NICU Apnea Bradycardia Guidelines (CP.MP.82) (PDF)
- NICU Discharge Guidelines (CP.MP.81) (PDF)
- Nonmyeloablative Allogeneic Stem Cell Transplants (CP.MP.141) (PDF)
- Orthognathic Surgery (CP.MP.202) (PDF)
- Osteogenic Stimulation (CP.MP.194) (PDF)
- Out of Network and Non-emergent Out of State Services (MI.CP.MP.528) (PDF)
- Pancreas Transplantation (CP.MP.102) (PDF)
- Panniculectomy (CP.MP.109) (PDF)
- Pediatric Heart Transplant (CP.MP.138) (PDF)
- Pediatric Liver Transplant (CP.MP.120) (PDF)
- Physical, Occupational, and Speech Therapy Services (CP.MP.49) (PDF)
- Physician Advisory Committee (MI.CP.MP.539) (PDF)
- Posterior Nerve Stimulation for Voiding Dysfunction (CP.MP.133) (PDF)
- Readmission Review (MI.CP.MP.505) (PDF)
- Reduction Mammoplasty and Gynecomastia Surgery (CP.MP.51) (PDF)
- Relizorb (MI.CP.MP.504) (PDF)
- Sclerotherapy and Chemical Endovenous Ablation for Varicose Veins and Other Symptomatic Venous Disorders (CP.MP.146) (PDF)
- Short Inpatient Hospital Stay (MI.CP.MP.182) (PDF)
- Skin and Soft Tissue Substitutes for Chronic Wounds (CP.MP.185) (PDF)
- Spinal Cord, Peripheral Nerve, and Percutaneous Electrical Nerve Stimulation (CP.MP.117) (PDF)
- Stereotactic Body Radiation Therapy (CP.MP.22) (PDF)
- Tandem Transplant (CP.MP.162) (PDF)
- Therapeutic Utilization of Inhaled Nitric Oxide (CP.MP.87) (PDF)
- Urinary Incontinence Devices and Treatments (CP.MP.142) (PDF)
- Ventricular Assist Devices (CP.MP.46) (PDF)
For Medicare information, please visit our Medicare Prior Authorization website.
Payment Policies
Health care claims payment policies are guidelines used to assist in administering payment rules based on generally accepted principles of correct coding. They are used to help identify whether health care services are correctly coded for reimbursement. Each payment rule is sourced by a generally accepted coding principle. They include, but are not limited to claims processing guidelines referenced by the Centers for Medicare and Medicaid Services (CMS), Publication 100-04, Claims Processing Manual for physicians/non-physician practitioners, the CMS National Correct Coding Initiative policy manual (procedure-to-procedure coding combination edits and medically unlikely edits), Current Procedural Technology guidance published by the American Medical Association (AMA) for reporting medical procedures and services, health plan clinical policies based on the appropriateness of health care and medical necessity, and at times state-specific claims reimbursement guidance.
All policies found in the Meridian Payment Policy Manual apply with respect to Meridian members. Policies in the Meridian Payment Policy Manual may have either a Meridian or a “Centene” heading. In addition, Meridian may from time to time employ a vendor that applies payment policies to specific services; in such circumstances, the vendor’s guidelines may also be used to determine whether a service has been correctly coded. Other policies (e.g., clinical policies) or contract terms may further determine whether a technology, procedure or treatment that is not addressed in the Payment Policy Manual is payable by Meridian.
If you have any questions regarding these policies, please contact Member Services and ask to be directed to the Medical Management department.
CC.PI.04 Clean Claim Reviews (PDF)
CC.PI.06 Cost to Charge Adjustments on Clean Claim Reviews (PDF)
CC.PP.007 Maximum Units of Service (PDF)
CC.PP.009 Unlisted Procedure Codes (PDF)
CC.PP.010 EM Bundling with Labs and Radiology (PDF)
CC.PP.011 Code Editing Overview (PDF)
CC.PP.012 Intravenous Hydration (PDF)
CC.PP.015 Moderate Conscious Sedation (PDF)
CC.PP.016 Reporting the Global Maternity Package (PDF)
CC.PP.017 Never Paid Events (PDF)
CC.PP.018 Inpatient Only Procedures (PDF)
CC.PP.019 Professional Services Billed With Labs (PDF)
CC.PP.020 Distinct Procedural Modifiers (PDF)
CC.PP.023 Hospital Visit Codes Billed with Labs (PDF)
CC.PP.024 Cosmetic Procedures (PDF)
CC.PP.025 Pulse Oximetry with Office Visits (PDF)
CC.PP.027 Professional Component Modifier (PDF)
CC.PP.028 Modifier to Procedure Code Validation (PDF)
CC.PP.029 Assistant Surgeon (PDF)
CC.PP.030 Add-on Code Billed without Primary Code (PDF)
CC.PP.031 NCCI Unbundling (PDF)
CC.PP.032 Supplies billed on Same day as Surgery (PDF)
CC.PP.033 Multiple CPT Code Replacement (PDF)
CC.PP.034 Modifier DOS Validation (PDF)
CC.PP.035 Sleep Studies Place of Service (PDF)
CC.PP.036 New Patient (PDF)
CC.PP.037 Bilateral Services (PDF)
CC.PP.038 Inpatient Consultation (PDF)
CC.PP.039 Outpatient Consultation (PDF)
CC.PP.040 Same Day Visits (PDF)
CC.PP.041 Preoperative Visits (PDF)CC.PP.050 Robotic Surgery (PDF)
CC.PP.056 Urine Specimen Validity Testing (PDF)
CC.PP.061 NonOB and OBTA and Transvaginal Ultrasounds (PDF)
CC.PP.063 Place of Service Mismatch (PDF)
CC.PP.065 Multiple Diagnostic Cardiovascular Procedure Payment Reduction (MDCR) (PDF)
CC.PP.066 Leveling of Care Evaluation and Management Overcoding (PDF)
CC.PP.067 Renal Hemodialysis (PDF)
CC.PP.068 Multiple Procedure Payment Reduction for Therapeutic Services (PDF)
CC.PP.069 Multiple Procedure Reduction Ophthalmology (PDF)
CC.PP.073 Sepsis Diagnosis (PDF)
CC.PP.206 Skilled Nursing Facility Leveling (PDF)
CC.PP.500 3 Day Payment Window (PDF)
CC.PP.502 Wheelchair Accessories (PDF)
CP.MP.105 Digital EEG Spike Analysis (PDF)
CG.CC.PP.01 Concert Laboratory Payment Policy (PDF)
Effective date: 6/1/24
CG.CP.MP.01 Infectious Disease: Respiratory Lab Testing (PDF)
Effective date: 6/1/24
CG.CP.MP.02 Infectious Disease: Multisystem Lab Testing (PDF)
Effective date: 6/1/24
CG.CP.MP.03 Infectious Disease: Dermatologic Lab Testing (PDF)
Effective date: 6/1/24
CG.CP.MP.04 Infectious Disease: Gastroenterologic Lab Testing (PDF)
Effective date: 6/1/24
CG.CP.MP.05 Infectious Disease: Primary Care & Preventive Lab Screening (PDF)
Effective date: 6/1/24
CG.CP.MP.06 Infectious Disease: Vector-borne and Tropical Diseases Lab Testing (PDF)
Effective date: 6/1/24
CG.CP.MP.07 Infectious Disease: Genitourinary Lab Testing (PDF)
Effective date: 6/1/24
CG.PP.551 Genetic and Molecular Testing Services (PDF)
Effective date: 6/1/24